Tenax Therapeutics, Inc. is a development-stage pharmaceutical company focused on cardiopulmonary therapies. The company develops treatments for serious cardiovascular and pulmonary conditions, with a primary emphasis on pulmonary hypertension associated with heart failure with preserved ejection fraction. Its pipeline includes levosimendan-based programs, as well as other drug candidates aimed at improving outcomes in heart and lung disease. Tenax Therapeutics concentrates on advancing clinical-stage therapies for patients with high unmet medical needs, making it a specialized player in the pharmaceutical market. Headquartered in Chapel Hill, North Carolina, Tenax Therapeutics operates as a research-driven company centered on novel treatments for complex cardiopulmonary disorders.
Website101 Glen Lennox Drive
Chapel Hill, NC, 27517
United States
Detailed price information for Tenax Therapeutics (TENX-Q) from The Globe and Mail including charting and trades.
Detailed price information for Kura Oncology (KURA-Q) from The Globe and Mail including charting and trades.
Tenax Therapeutics, Inc. (NASDAQ:TENX) has a possible route forward for TNX-103, but the Phase 3 LEVEL trial did not establish efficacy in the overall population. The study evaluated oral levosimendan in 241 patients with pulmonary hypertension associated with heart failure with preserved ejection fraction, or PH-HFpEF. At Week 12, the adjusted improvement in six-minute walk […]
Investors talking about TENX also mention
What share of all stock conversation is about TENX?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0% +0 | 0% 0 | 0.01% -0.03 | 0% +0 |
Of the messages about TENX that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | 100% 0 | 100% +12.24 | 83.56% +60.17 | 38.47% -45.94 | ||
| Bearish | 0% 0 | 0% -12.24 | 16.44% -60.17 | 61.53% +45.94 |
Of the messages about TENX that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Announcements | — | 57.14% | 73.37% | 21.59% | ||
| Technical Analysis | — | 42.86% | 11.49% | 1.85% | ||
| Analysts | — | 0% | 14.88% | 36.46% | ||
| Macro | — | 0% | 0% | 39.42% | ||
| Controversies | — | 0% | 0.26% | 0.06% | ||
| Earnings | — | 0% | 0% | 0.62% |
Of the messages about TENX, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | 25% | 18.75% | 12.13% | 21.95% | ||
| Newcomers | 75% | 81.25% | 87.87% | 78.05% |